Bristol-Myers Squibb makes new appointment
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibbhas appointed Dr Howard Feldman vice-president and therapeutic head area of global clinical research, neuroscience, in the company's R&D organisation. Dr Feldman will help continue to build the R&D pipeline, leading clinical research strategy in neurological and psychiatric disorders. He previously held the position of professor and head of the division of neurology at the University of British Columbia (UBC), as well as director of the clinic for Alzheimer's disease and related disorders at UBC hospital.